| Financial Year |
March 31 2023 |
| Monetary Funds |
202,125,681.70 |
| Held-for-trading Financial Assets |
103,444,576.45 |
| Notes Receivable |
-- |
| Accounts Receivable |
460,105,330.54 |
| Advances to Suppliers |
10,219,865.61 |
| Other Receivables |
6,166,281.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
436,537,970.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,391,936.98 |
| Total Current Assets |
1,371,655,703.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
187,699,516.75 |
| Fixed Assetes |
664,344,764.81 |
| Under-construction Projects |
44,548,775.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,321,193.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
14,735,951.36 |
| Other Non-Current Assets |
14,304,869.48 |
| Sub-Total of Non-Current Assets |
982,955,070.74 |
| Total Assets |
2,354,610,774.27 |
| Short-Term Loans |
153,156,333.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
190,774,246.78 |
| Accounts Payable |
449,959,568.22 |
| Accounts Received In Advance |
11,990,051.08 |
| Employee Compensation Payable |
19,407,548.18 |
| Taxes Payable |
5,383,490.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,539,532.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
37,185,134.90 |
| Sub-Total of Current Liabilities |
886,141,191.41 |
| Long-term Loans |
53,824,172.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,391,579.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
85,435,510.02 |
| Total Liabilities |
971,576,701.43 |
| Paid-In Capital(Or Share Stock) |
789,644,637.00 |
| Capital Surplus |
182,334,093.78 |
| Surplus Reserve |
137,936,874.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
291,815,421.57 |
| Minority Stockholder's Interest |
-18,696,954.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,401,731,027.16 |
| Owner's Equity（Stockholder's Equity） |
1,383,034,072.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,354,610,774.27 |
